[1]
“Cost-Effectiveness Analysis of Two or Three Dosage Forms of N-Acetylcysteine in ICU Patients with Pneumonia”, JFM, vol. 8, no. 1, pp. 166–172, Nov. 2025, doi: 10.35451/s13m6d29.